Thrombotic Thrombocytopenic Purpura
📧 Sign up to get email alerts when something new happens for Thrombotic Thrombocytopenic Purpura.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2019-02-19Clinical Trial Update: The Role of Microparticles as a Biomarker
A University of Rochester trial evaluating microparticles as a biomarker for atypical hemolytic uremic syndrome and thrombotic thrombocytope…
-
CLINICAL_TRIALS withdrawal · 2013-04-17Clinical Trial Update: The Plasma Large-Volume Exchange RCT [Phase 3]
A Phase 3 randomized trial of plasma exchange for thrombotic thrombocytopenic purpura and hemolytic uremic syndrome has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-12-21Clinical Trial Update: Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura [Phase 4]
The Phase 4 trial of prophylactic plasma infusion therapy for congenital thrombotic thrombocytopenic purpura has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-11-15Clinical Trial Update: Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura [Phase 1, Phase 2]
A clinical trial evaluating rituximab in addition to standard care for newly presenting thrombotic thrombocytopenic purpura has been withdra…